Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings

Nephrology

Volumn 10, Issue 3, 2005, Pages 311-316

  Uǧuz, Aysun ^a   Gönlüşen, Gülfiliz ^a   Ergin, Melek ^a   Tuncer, Ilhan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Bcl 2; Fas; Glomerulonephritis; p53

Indexed keywords

CELL SURFACE PROTEIN; FAS ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANTIGEN EXPRESSION; APOPTOSIS; AUTOIMMUNE DISEASE; CELL DEATH; CELL SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 21344433496     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00397.x     Document Type: Conference Paper

References (41)

1. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K. Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int. 1995; 48: 1886-92.
2. Ortiz A, Gonzalez C, Lorz C, Egido J. Apoptosis in renal diseases. Front. Biosci. (Electronic journal) 1996; 1: D30-47. Available from: http://www.bioscience.org/1996/vl/d/ortiz1/htmls/30-47.htm
3. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
4. Ortiz A, Lorz C, Egido J. The Fas ligand/ Fas system in renal injury. Nephrol. Dial. Transplant. 1999; 14: 1831-4.
5. Gonzalez C, Lorz C, Garcia del Moral R et al. Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int. 1997; 51: 1739-46.
6. Johnson RJ. The glomerular response to injury: Progression or resolution? Kidney Int. 1994; 45: 1769-82.
7. Gonzalez-Cuadrado S, Lopez-Armada MJ, Gommez-Guerrero C et al. Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int. 1996; 49: 1064-70.
8. Ortiz-Arduan A, Danoff TM, Kalluri R et al. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am. J. Physiol. 1996; 241: F1193-201.
9. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am. J. Pathol. 1997; 151: 1231-9.
10. Shimuzu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis. Nephron. 1998; 79: 206-14.
11. Ortiz A, Lorz C, Egido J. New kids in the block: The role of FasL and Fas in kidney damage. J. Nephrol. 1999; 12: 150-58.
12. Sano H, Asano K, Minatoguchi S et al. Plasma soluble Fas and soluble Fas ligand in chronic glomerulonephritis. Nephron. 1998; 80: 153-61.
13. Omori S, Morioka T, Wakasugi M et al. Quantification of apoptotic cells using isolated glomeruli. Nephron. 1997; 77: 474-8.
14. Ottiz A, Justo P, Catalan MP, Sanz AB, Lorz C, Egido J. Apoptotic cell death in renal injury: The rationale for intervention. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002; 2: 181-92.
15. Cotran RS, Kumar V, Collins T. Robbins Pathologic Basis of Disease, 6th edn. Philadelphia: WB Saunders Company, 1999.
16. Varadhachary AS, Salgame P. CD95 mediated T cell apoptosis and its relevance to immune deviation. Oncogene 1998; 17: 3271-6.
17. Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death. Blood 1996; 88: 386-01.
18. Hetts SW. Today or not today. JAMA 1998; 279: 300-7.
19. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H. Genetic control of programmed cell death in drosophila. Science 1994; 264: 677-83.
20. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-9.
21. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397-400.
22. Liston P, Roy N, Tamai K et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379: 349-53.
23. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-8.
24. Green DR. Apoptosis: Death deceiver. Nature 1998; 396: 629-30.
25. Golstein P. Controlling cell death. Science 1997; 275: 1081-2.
26. Hattori T, Shindo S, Kawamura H. Apoptosis and expression of Bax protein and Fas antigen in glomeruli of remnant-kidney model. Nephron. 1998; 79: 186-91.
27. Clement MV, Stamenkovic I. Fas and tumor necrosis factor receptor mediated cell death: Similarities and distinctions. J. Exp. Med. 1994; 180: 557-67.
28. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-55.
29. Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflammatory effects of Fas ligand (CD95). Science 1998; 282: 1714-7.
30. Akbar AN. Life (and death) in the Fas lane. Gut 1998; 43: 5-6.
31. Yasutomo K, Nagasawa H, Uehara H et al. The novel regulatory mechanism of Fas system-mediated apoptosis in mesangial cells: Implication to mesangial proliferative glomerulonephritis. Biochem. Biophys. Res. Commun. 1996; 219: 89-95.
32. Reed JC. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 1994; 124: 1-6.
33. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 387: 773-6.
34. Hengartner MO. Death cycle and Swiss army knives. Nature 1998; 391: 441-2.
35. Sandau K, Pfeilschifter J, Brüne B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int. 1997; 52: 378-86.
36. Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissber P. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis. Science 1998; 282: 290-93.
37. Takemura T, Okada M, Akano N et al. Proto-oncogene expression in human glomerular diseases. J. Pathol. 1996; 178: 343-51.
38. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 1994; 94: 2105-16.
39. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Apoptosis in glomerular sclerosis. Kidney Int. 1996; 49: 103-11.
40. Lu F, Shen W, Zhang X, Guo M, Lin S. Dysregulation of apoptosis: A possible mechanism leading to chronic progressive renal histological changes in lupus nephritis. Chin. Med. J. 2000; 113: 1082-6.
41. Rodriguez-Lopez AM, Flores O, Arevalo MA, Lopez-Novoa JM. Glomerular cell proliferation and apoptosis in uninephrectomized spontaneously hypertensive rats. Kidney Int. 1998; 54: 36-40.